132 related articles for article (PubMed ID: 12581020)
1. In vivo evaluation of the potency and bladder-vascular selectivity of the ATP-sensitive potassium channel openers (-)-cromakalim, ZD6169 and WAY-133537 in rats.
Fabiyi AC; Gopalakrishnan M; Lynch JJ; Brioni JD; Coghlan MJ; Brune ME
BJU Int; 2003 Feb; 91(3):284-90. PubMed ID: 12581020
[TBL] [Abstract][Full Text] [Related]
2. Effects of ATP-sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstruction.
Fey TA; Gopalakrishnan M; Strake JG; King LL; Brioni JD; Sullivan JP; Coghlan MJ; Brune ME
Neurourol Urodyn; 2003; 22(2):147-55. PubMed ID: 12579633
[TBL] [Abstract][Full Text] [Related]
3. K-ATP opener-mediated attenuation of spontaneous bladder contractions in ligature-intact, partial bladder outlet obstructed rats.
Lynch JJ; Brune ME; Lubbers NL; Coghlan MJ; Cox BF; Polakowski JS; King LL; Sullivan JP; Brioni JD
Life Sci; 2003 Mar; 72(17):1931-41. PubMed ID: 12597992
[TBL] [Abstract][Full Text] [Related]
4. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. in vivo characterization.
Brune ME; Fey TA; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ; Gopalakrishnan M
J Pharmacol Exp Ther; 2002 Oct; 303(1):387-94. PubMed ID: 12235275
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat.
Wojdan A; Freeden C; Woods M; Oshiro G; Spinelli W; Colatsky TJ; Sheldon JH; Norton NW; Warga D; Antane MM; Antane SA; Butera JA; Argentieri TM
J Pharmacol Exp Ther; 1999 Jun; 289(3):1410-8. PubMed ID: 10336534
[TBL] [Abstract][Full Text] [Related]
6. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization.
Gopalakrishnan M; Buckner SA; Whiteaker KL; Shieh CC; Molinari EJ; Milicic I; Daza AV; Davis-Taber R; Scott VE; Sellers D; Chess-Williams R; Chapple CR; Liu Y; Liu D; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ
J Pharmacol Exp Ther; 2002 Oct; 303(1):379-86. PubMed ID: 12235274
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of urinary bladder smooth muscle contractility following partial bladder outlet obstruction in pigs.
Milicic I; Buckner SA; Daza A; Coghlan M; Fey TA; Brune ME; Gopalakrishnan M
Eur J Pharmacol; 2006 Feb; 532(1-2):107-14. PubMed ID: 16487510
[TBL] [Abstract][Full Text] [Related]
8. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canine.
Fryer RM; Preusser LC; Calzadilla SV; Hu Y; Xu H; Marsh KC; Cox BF; Lin CT; Gopalakrishnan M; Reinhart GA
J Cardiovasc Pharmacol; 2004 Aug; 44(2):137-47. PubMed ID: 15243293
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of intravesical versus extravesical administration of ZD6169 and cromakalim on the response of the in vitro rat whole bladder to field stimulation.
Chun A; Bertelsen DL; Murphy J; Kau S; Levin RM
Pharmacology; 1996 Jun; 52(6):347-52. PubMed ID: 8844784
[TBL] [Abstract][Full Text] [Related]
10. K-channel opening activity of ZD6169 and its analogs: effect on 86Rb efflux and 3H-P1075 binding in bladder smooth muscle.
Trivedi S; Stetz SL; Potter-Lee L; McConville M; Li JH; Empfield J; Ohnmacht CJ; Russell K; Brown FJ; Trainor DA
Pharmacology; 1995 Jun; 50(6):388-97. PubMed ID: 7568338
[TBL] [Abstract][Full Text] [Related]
11. ZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder.
Howe BB; Halterman TJ; Yochim CL; Do ML; Pettinger SJ; Stow RB; Ohnmacht CJ; Russell K; Empfield JR; Trainor DA
J Pharmacol Exp Ther; 1995 Aug; 274(2):884-90. PubMed ID: 7636752
[TBL] [Abstract][Full Text] [Related]
12. Effect of KATP channel openers on myogenic and neurogenic responses in goat urinary bladder.
Vijayakumar C; Kathirvel K; Sardar KK; Parija SC
Indian J Exp Biol; 2007 Feb; 45(2):185-93. PubMed ID: 17375559
[TBL] [Abstract][Full Text] [Related]
13. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.
Butera JA; Antane MM; Antane SA; Argentieri TM; Freeden C; Graceffa RF; Hirth BH; Jenkins D; Lennox JR; Matelan E; Norton NW; Quagliato D; Sheldon JH; Spinelli W; Warga D; Wojdan A; Woods M
J Med Chem; 2000 Mar; 43(6):1187-202. PubMed ID: 10737752
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravesical administration of the K+ channel opener, ZD6169, in conscious rats with and without bladder outflow obstruction.
Pandita RK; Andersson KE
J Urol; 1999 Sep; 162(3 Pt 1):943-8. PubMed ID: 10458413
[TBL] [Abstract][Full Text] [Related]
15. Effects of ZD6169 and ZD0947, 2 potassium adenosine triphosphate channel openers, on bladder function of spinalized rats.
Abdel-Karim AM; Bialecki RA; Elhilali MM
J Urol; 2002 Aug; 168(2):837-42. PubMed ID: 12131377
[TBL] [Abstract][Full Text] [Related]
16. Zeneca ZD6169 and its analogs from a novel series of anilide tertiary carbinols: in vitro KATP channel opening activity in bladder detrusor.
Li JH; Yasay GD; Zografos P; Kau ST; Ohnmacht CJ; Russell K; Empfield JR; Brown FJ; Trainor DA; Bonev AD
Pharmacology; 1995 Jun; 51(1):33-42. PubMed ID: 7568342
[TBL] [Abstract][Full Text] [Related]
17. Effects of ZD6169, a K(ATP) channel opener, on the micturition reflex in the rat.
Yu Y; de Groat WC
J Pharmacol Exp Ther; 1999 Aug; 290(2):825-31. PubMed ID: 10411598
[TBL] [Abstract][Full Text] [Related]
18. Effects of the K+ channel opener, ZD6169, on volume and PGE2-stimulated bladder activity in conscious rats.
Pandita RK; Persson K; Andersson KE
J Urol; 1997 Dec; 158(6):2300-4. PubMed ID: 9366380
[TBL] [Abstract][Full Text] [Related]
19. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
Kaiho Y; Nishiguchi J; Kwon DD; Chancellor MB; Arai Y; Snyder PB; Yoshimura N
BJU Int; 2008 Mar; 101(5):615-20. PubMed ID: 18070178
[TBL] [Abstract][Full Text] [Related]
20. Zeneca ZD6169 activates ATP-sensitive K+ channels in the urinary bladder of the guinea pig.
Heppner TJ; Bonev A; Li JH; Kau ST; Nelson MT
Pharmacology; 1996 Sep; 53(3):170-9. PubMed ID: 8931102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
